Kindly MD, Inc. Price & Performance (KDLY)

Solid Biosciences is set to present data from its ongoing INSPIRE DUCHENNE trial at the MDA Clinical & Scientific Conference. The study focuses on SGT-003, a promising gene therapy for Duchenne muscular dystrophy. The presentation will occur on March 19, 2025, showcasing advancements in treating this severe neuromuscular disease.1

Avidity Biosciences will host a forum on RNA therapeutics during the MDA Conference. The event, featuring key opinion leaders, will discuss advancements in Antibody Oligonucleotide Conjugates. Avidity will also present data from its EXPLORE44 trial, emphasizing its commitment to addressing rare neuromuscular diseases.2

TeraWulf is actively participating in notable conferences, including the Roth Conference and NVIDIA GTC 2025. The company aims to strengthen its position in zero-carbon digital infrastructure by engaging with industry leaders and showcasing its innovative approaches to sustainable technology.3